MedWellAI flags going-concern doubt as revenue falls
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
MedWellAI, Inc. reported revenue of $76,390 for the three months ended September 30, 2026, versus $117,387 a year earlier; commissions were $76,390 and rental income was zero after its sole lease customer said on June 1, 2026, that it would not renew. Net loss attributable to shareholders narrowed to $287,173 from $651,878, while operating cash used fell to $101,182 from $170,781. Cash was $180,040 against current liabilities of $8,331,076.
As of September 30, 2026, current liabilities exceeded current assets by $8,133,007 and accumulated deficit was $90,550,518; MedWellAI said these conditions raise substantial doubt about its ability to continue as a going concern. A $500,000 promissory note was in default, with arrears of $611,799 as of November 16, 2026. A July 21, 2026, $225,000 convertible note produced $195,000 in net proceeds and calls for a $126,000 payment on December 29, 2026, followed by $21,000 monthly payments. Management concluded internal control over financial reporting was ineffective and identified three material weaknesses.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointShareholder-attributable loss narrowed to $287,173 from $651,878.
- Moderate pointOperating cash use fell to $101,182 from $170,781.
Negative
- Major pointWorking-capital deficit reached $8,133,007; management cited substantial doubt about going concern.
- Major pointThree material weaknesses left internal control over financial reporting ineffective.
- Major pointDefaulted note arrearage totaled $611,799 as of November 16, 2026. 60% of market cap
- Moderate pointQuarterly revenue fell to $76,390 from $117,387.
Filing Explained
As of September 30, 2026, 33,312,500 potentially dilutive preferred-conversion shares were excluded from diluted earnings per share, not reported as issued common shares.
MedWellAI reports that 6,500 Series C preferred shares were outstanding as of
As of
Key Figures
Key Terms
going concern financial
material weakness financial
original issue discount financial
anti-dilutive financial
beneficial ownership limitations regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were MedWellAI (MWAI)’s revenue and net loss for the quarter?
Why did MedWellAI (MWAI) cite substantial doubt about its ability to continue as a going concern?
How can the holder convert MedWellAI’s (MWAI) July 2026 convertible note?
What material weaknesses did MedWellAI (MWAI) report?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the quarterly period ended | |
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from __________ to __________ | |
Commission file number:
(Exact Name of Registrant as Specified in Its Charter) |
| ||
(State or Other Jurisdiction of Incorporation or Organization) |
| (I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(
(Registrant’s Telephone Number, Including Area Code)
Securities registered under Section 12(b) of the Exchange Act: None.
Securities registered under Section 12(g) of the Exchange Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
N/A |
| N/A |
| N/A |
Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
Emerging growth company |
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐ No ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As of November 13, 2026, the registrant had
TABLE OF CONTENTS
Page |
| |||
PART I: FINANCIAL INFORMATION |
| |||
| ||||
Item 1. | Financial Statements | F-1 |
| |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| 3 |
|
Item 3. | Quantitative and Qualitative Disclosures About Market Risk |
| 10 |
|
Item 4. | Controls and Procedures |
| 10 |
|
|
|
| ||
PART II: OTHER INFORMATION |
| |||
|
| |||
Item 1. | Legal Proceedings |
| 12 |
|
Item 1A. | Risk Factors |
| 12 |
|
Item 2. | Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities |
| 12 |
|
Item 3. | Defaults upon Senior Securities |
| 12 |
|
Item 4. | Mine Safety Disclosures |
| 12 |
|
Item 5. | Other Information |
| 12 |
|
Item 6. | Exhibits |
| 13 |
|
|
|
| ||
SIGNATURES |
| 14 |
| |
2 |
| Table of Contents |
PART I – FINANCIAL INFORMATION
INDEX TO FINANCIAL STATEMENTS
|
| Page |
|
|
|
|
|
Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and June 30, 2026 |
| F-2 |
|
|
|
|
|
Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2026 and 2025 (unaudited) |
| F-3 |
|
|
|
|
|
Condensed Consolidated Statement of Stockholders’ Equity (Deficit) for the Three Months Ended September 30, 2026 and 2025 (unaudited) |
| F-4 |
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for Three Months Ended September 30, 2026 and 2025 (unaudited) |
| F-5 |
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements as of September 30, 2026 (unaudited) |
| F-6 |
|
| F-1 |
| Table of Contents |
MedWellAI, Inc. | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
| ||||||||
|
| September 30, |
|
| June 30, |
| ||
|
| 2026 |
|
| 2026 |
| ||
|
| (Unaudited) |
|
|
| |||
|
|
|
|
|
|
| ||
ASSETS |
|
|
|
|
|
| ||
Current assets: |
|
|
|
|
|
| ||
Cash |
| $ |
|
| $ |
| ||
Receivables |
|
|
|
|
|
| ||
Prepaid expenses and other current assets |
|
|
|
|
|
| ||
Deposits, Current |
|
|
|
|
|
| ||
Total current assets |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Other assets: |
|
|
|
|
|
|
|
|
Property and equipment, net |
|
|
|
|
|
| ||
Intangible assets, net |
|
|
|
|
|
| ||
Total other assets |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
| $ |
|
| $ |
| ||
Accrued expenses |
|
|
|
|
|
| ||
Due to related party |
|
|
|
|
|
| ||
Notes payable in default, net of debt discount |
|
|
|
|
|
| ||
Convertible notes payable, net of debt discount |
|
|
|
|
|
| ||
Series C convertible preferred stock, $ |
|
|
|
|
|
| ||
Total current liabilities |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Stockholders' equity (deficit): |
|
|
|
|
|
|
|
|
Series A preferred stock, $ |
|
|
|
|
|
| ||
Series B preferred stock, $ |
|
|
|
|
|
| ||
Common stock payable |
|
|
|
|
|
| ||
Common stock, $ |
|
|
|
|
|
| ||
Additional paid in capital |
|
|
|
|
|
| ||
Accumulated deficit |
|
| ( | ) |
|
| ( | ) |
Total Stockholders' deficit of MedWellAI, Inc. and Subsidiaries |
|
| ( | ) |
|
| ( | ) |
Noncontrolling interest |
|
|
|
|
|
| ||
Total stockholders' deficit |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' deficit |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated financial statements. | ||||||||
| F-2 |
| Table of Contents |
MedWellAI, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
|
| Three Months Ended September 30, |
| |||||
|
| 2026 |
|
| 2025 |
| ||
|
|
|
|
|
|
| ||
Revenue: |
|
|
|
|
|
| ||
Commissions |
| $ |
|
| $ |
| ||
Rental income |
|
| |
|
|
|
| |
Total revenue |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Costs and expenses: |
|
|
|
|
|
|
|
|
Cost of revenues - rent |
|
|
|
|
|
| ||
General and administrative |
|
|
|
|
|
| ||
Depreciation and amortization |
|
|
|
|
|
| ||
Total operating expenses |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Income (loss) from operations |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
Other income |
|
|
|
|
|
| ||
Interest expense |
|
| ( | ) |
|
| ( | ) |
Loss on exchange of Series C & D preferred shares |
|
|
|
|
| ( | ) | |
Total other income (expense) |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
Income (loss) from continued operations before income taxes |
|
| ( | ) |
|
| ( | ) |
Provision for income taxes |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Net income (loss) from continued operations |
|
| ( | ) |
|
| ( | ) |
Net income (loss) from discontinued operations |
|
|
|
|
| ( | ) | |
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
| ( | ) |
|
| ( | ) |
Net income (loss) attributable to noncontrolling interest |
|
| ( | ) |
|
| ( | ) |
Net income (loss) attributable to MedWellAI, Inc. |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
Dividends on Preferred Stock |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to shareholders |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
Continuing operations: |
|
|
|
|
|
|
|
|
Net income (loss) per common share attributable to shareholders, basic |
| $ | ( | ) |
| $ | ( | ) |
Net income (loss) per common share attributable to shareholders, diluted |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding, basic |
|
|
|
|
|
| ||
Weighted average number of common shares outstanding, diluted |
|
|
|
|
|
| ||
Discontinuing operations: |
|
|
|
|
|
|
|
|
Net income (loss) per common share attributable to shareholders, basic |
| $ |
|
| $ | ( | ) | |
Net income (loss) per common share attributable to shareholders, diluted |
| $ |
|
| $ | ( | ) | |
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding, basic |
|
|
|
|
|
| ||
Weighted average number of common shares outstanding, diluted |
|
|
|
|
|
| ||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| F-3 |
| Table of Contents |
MedWellAI, Inc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THREE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||||||||||||||
|
| Series C |
|
| Series D |
|
| Series A |
|
| Series B |
|
|
|
|
| Common |
|
| Additional |
|
|
|
|
| Non |
|
|
|
| ||||||||||||||||||||||||||||||
|
| Preferred Stock |
|
| Preferred Stock |
|
| Preferred Stock |
|
| Preferred Stock |
|
| Common Stock |
|
| Stock |
|
| Paid in |
|
| Accumulated |
|
| controlling |
|
|
| |||||||||||||||||||||||||||||||
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Shares |
|
| Amount |
|
| Payable |
|
| Capital |
|
| Deficit |
|
| Interest |
|
| Total |
| |||||||||||||||
Balance, June 30, 2025 |
|
|
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||||||||||||
Share exchange agreement with BHP Capital |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Common stock issued for services |
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||
Net loss |
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) | |||||||
Balance, September 30, 2025 |
|
| - |
|
| $ |
|
|
| - |
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, June 30, 2026 |
|
| - |
|
| $ |
|
|
| - |
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||||||||||
Rounding adjustment |
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
|
|
|
|
|
|
|
| |||||||||
Common stock payable for shares vested but not issued |
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
|
|
|
| ( | ) |
|
|
|
|
|
|
|
|
| |||||||||
Net loss |
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
| - |
|
|
|
|
|
|
|
|
|
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) | |||||||
Balance, September 30, 2026 |
|
| - |
|
| $ |
|
|
| - |
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
|
|
|
| $ |
|
| $ |
|
| $ |
|
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated financial statements. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| F-4 |
| Table of Contents |
MedWellAI, Inc. | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(Unaudited) | ||||||||
| ||||||||
|
| Three Months Ended September 30, |
| |||||
|
| 2026 |
|
| 2025 |
| ||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
| ||
Net income (loss) from continuing operations |
| $ | ( | ) |
| $ | ( | ) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
|
|
|
| ||
Debt discount amortization |
|
|
|
|
|
| ||
Stock-based compensation |
|
|
|
|
|
| ||
Loss on exchange of Series C & D preferred stock |
|
|
|
|
|
| ||
Lease cost, net of repayment |
|
|
|
|
|
| ||
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Receivables |
|
|
|
|
|
| ||
Prepaid expenses and other current assets |
|
|
|
|
| ( | ) | |
Accounts payable |
|
|
|
|
| ( | ) | |
Accrued expenses |
|
|
|
|
|
| ||
Deferred revenue |
|
|
|
|
| ( | ) | |
Due to related party |
|
|
|
|
|
| ||
Net cash provided by (used in) operating activities |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchase of leasehold improvements |
|
|
|
|
| ( | ) | |
Net cash provided by (used in) investing activities |
|
|
|
|
| ( | ) | |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Cash proceeds from convertible note payable |
|
|
|
|
|
| ||
Net cash provided by (used in) financing activities |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash |
|
|
|
|
| ( | ) | |
Cash, cash equivalents, and restricted cash - beginning of period |
|
|
|
|
|
| ||
Cash, cash equivalents, and restricted cash - end of period |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |
|
|
|
|
|
|
|
|
Cash paid during the period for: |
|
|
|
|
|
|
|
|
Interest |
| $ |
|
| $ |
| ||
Income taxes |
| $ |
|
| $ |
| ||
Non-cash investing and financing activities - continuing: |
|
|
|
|
|
|
|
|
Debt discount |
| $ |
|
| $ |
| ||
Original issue discount |
| $ |
|
| $ |
| ||
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed consolidated financial statements. | ||||||||
| F-5 |
| Table of Contents |
MedWellAI, Inc.
Notes to Condensed Consolidated Financial Statements
Three Months Ended September 30, 2026
(Unaudited)
1. ORGANIZATION AND BASIS OF PRESENTATION
Organization
We were incorporated in the State of Nevada on March 22, 2011 under the name Lightcollar, Inc. In March 2015, we changed our name to EMS Find, Inc. On May 30, 2017, Integrated Ventures, Inc. (“Integrated Ventures”), a Nevada corporation, was formed as a wholly owned subsidiary of the Company. Pursuant to an Agreement and Plan of Merger dated May 30, 2017, Integrated Ventures was merged into the Company, with the Company being the surviving corporation and changing its name to Integrated Ventures, Inc. In July 2024, the Company formed three wholly-owned subsidiaries, MedWell Direct, LLC (“MedWell Direct”), MedWell Facilities, LLC (“MedWell Facilities”), and MedWell USA, LLC (“MedWell USA”), all of which were organized in the State of Nevada. In June 2025, we changed our name to MedWellAI, Inc.
On August 29, 2024, the Company, through MedWell Direct, consummated its acquisition of
We are a publicly traded company (OTCQB: MWAI), based in Clearwater, Florida, that is focused on earning commissions through the use of a fully automated e-commerce platform that connects in-office buyers with multiple FDA-registered 503B pharmacies, offering GLP-1 weight management therapies, peptides and other compounds.
The Company also markets a turnkey, custom solution for qualified procurement agents and resellers to market in-office use products.
This e-commerce platform enables procurement agents and resellers to market products to licensed healthcare providers, wellness spas and telemedicine companies in a
Key features of the platform include access to multiple 503B outsourcing facilities, over 100 products, personalized pricing, direct payment deposits, custom domain options, and onboarding support.
The platform allows for seamless ordering, fulfillment, and shipping managed directly by the 503B facilities.
Basis of Presentation
The accompanying unaudited financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles ("US GAAP") for interim financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. The results of operations for the interim period ended September 30, 2026 shown in this report are not necessarily indicative of results to be expected for the full fiscal year ending June 30, 2027. In the opinion of the Company's management, the information contained herein reflects all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the Company's results of operations, financial position and cash flows. The unaudited interim financial statements should be read in conjunction with the audited financial statements in the Company's Annual Report on Form 10-K for the year ended June 30, 2026 filed on October 13, 2026 and Management's Discussion and Analysis of Financial Condition and Results of Operations.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The significant accounting policies of the Company are disclosed in Notes to Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2026 filed on October 13, 2026. The following summary of significant accounting policies of the Company is presented to assist in understanding the Company’s interim financial statements. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.
| F-6 |
| Table of Contents |
Use of Estimates
The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.
Reclassification
Certain accounts from prior periods have been reclassified to conform to the current period presentation.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, MedWell Direct, MedWell Facilities, and Medwell USA. The Company owns
All significant intercompany transactions and balances have been eliminated.
Cash and Cash Equivalents
The Company maintains cash balances in non-interest-bearing accounts that at times may exceed federally insured limits. For the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The Company had no cash equivalents at September 30, 2026.
Receivables
Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. We had an allowance for doubtful accounts of $
Property and Equipment
Property and equipment, consisting primarily of computer, other equipment, and leasehold improvements is stated at the lower of cost or estimated realizable value and is depreciated when placed into service using the straight-line method over estimated useful lives. Management has assessed the basis of depreciation of these assets and believes they should be depreciated over three – five years depending on the asset. Computers, due to their technological obsolescence reflecting rapid development of hardware that have faster processing capacity and other factors are depreciated over three years. Leasehold improvements are depreciated over five years representing the lease term. Maintenance and repairs are expensed as incurred and improvements are capitalized. Gains or losses on the disposition of property and equipment are recorded upon disposal.
Intangible Assets
The Company accounts for its intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs to renew or extend the term of intangible assets are recognized as an expense when incurred.
| F-7 |
| Table of Contents |
Impairment of Long-Lived Assets
All assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 350 and ASC 360. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value or net realizable value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.
Leases
The Company follows the provisions of ASC 842, and records right-of-use (“ROU”) assets and lease obligations for its operating leases, which are initially recognized based on the discounted future lease payments over the term of the lease. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. If the rate implicit in the Company's leases is not readily determinable, the Company's applicable incremental borrowing rate is used in calculating the present value of the sum of the lease payments.
The lease term is defined as the non-cancelable period of the lease plus any options to extend or terminate the lease when it is reasonably certain that the Company will exercise the option. The Company has elected not to recognize ROU asset and lease obligations for its short-term leases, which are defined as leases with an initial term of
Discontinued Operations
The Company follows the provisions of ASC 205-20, Presentation of Discontinued Operations, which requires separate reporting if a company sells part of its business. In order to recognize discontinued operation a major product line or division of an entity must be both a component and a strategic shift in operations. The Company assessed its digital asset mining business in June 2024 and determined it met the criteria of ASC 205-20. We disclosed our discontinued operations separately in the consolidated balance sheets, statements of operations, and statements of cash flows as items held for sale and discontinued operations. See Note 13.
Convertible Preferred Stock
The Company follows the provisions of ASC 480, Distinguishing Liabilities from Equity in determining if a financial instrument should be classified as a liability or equity on the balance sheet. This standard provides, among others, that the conversion of preferred stock into a variable number of equity shares and at inception, the monetary value is fixed, the instrument should be classified as a liability. As such upon the exchange of the Series C & D preferred shares on August 1, 2025 into convertible preferred stock, the Company determined the Series C convertible preferred stock met the requirements to be classified as a liability. Further, due to their convertible nature at any time at the option of the holder they are presented as current liability on the balance sheet.
Stock-Based Compensation
The Company accounts for all equity-based payments in accordance with ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock awards, stock options, warrants and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The fair value of a stock award is recorded at the fair market value of a share of the Company’s stock on the grant date. The Company estimates the fair value of stock options and warrants at the grant date by using an appropriate fair value model such as the Black-Scholes option pricing model or multinomial lattice models.
| F-8 |
| Table of Contents |
Revenue Recognition
We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. This standard provides a single comprehensive model to be used in the accounting for revenue arising from contracts with customers, including industry-specific guidance. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects in the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.
The following table presents the Company’s revenue by revenue source:
|
| Three Months Ended September 30 |
| |||||
|
| 2026 |
|
| 2025 |
| ||
|
|
|
|
|
|
| ||
Commissions |
| $ |
|
| $ |
| ||
Rental income |
|
|
|
|
|
| ||
|
| $ |
|
| $ |
| ||
Commissions
The Company earns commissions by informing, educating, and initiating sales of health and wellness products offered by a third party to customers. The commissions earned is based on the gross sales of products to customers less costs and fees. Through the use of their e-commerce platform, the third party computes the commission payable after each sale. The third party then pays the Company the amount due. The transactions price is set as the commissions to be received based on the agreed terms. The commissions are earned at a point in time upon the successful sale of products to a customer.
The timing of commission revenue recognition may differ from the timing of payment by the Company’s customers. The Company records a receivable when revenue is recognized prior to payment and there is an unconditional right to payment. As of September 30, 2026, the Company had receivables from commissions of $
Rental Income
The Company recognizes rent revenue from the lease of its sub-leased properties in accordance with ASC 842, Leases. The sub-lease is categorized as an operating lease according to ASC criteria for the lease definitions. Rent revenue is recognized on a straight-line basis over the lease term, reflecting the pattern of the economic benefits derived from the lease.
The Company’s leases generally have fixed rental payments over the lease term, with occasional escalations based on predetermined factors. Rent revenue is recognized monthly as the lessor fulfills its obligations under the lease agreement.
Any lease incentives or concessions provided to lessees, such as rent-free periods or tenant improvement allowances, are recognized as a reduction of rent revenue over the lease term.
During the year ended June 30, 2026, the Company had only one lease arrangement with a single customer. On June 1, 2026 the customer notified the Company the lease would not be renewed.
| F-9 |
| Table of Contents |
Income Taxes
Income taxes are recorded in accordance with ASC Topic 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statement or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.
Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the consideration of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Changes in assumptions in future periods may require we adjust our valuation allowance, which could materially impact our financial position and results of operations. The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on its income tax return, if such a position is more likely than not to be sustained.
Net Income (Loss) Per Share
Basic net income or loss per share is calculated by dividing net income or loss by the weighted average number of common shares outstanding for the period. Diluted income or loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock, such as “in-the-money” stock options and warrants, convertible debt and convertible preferred stock, were exercised or converted into common stock. Equivalent shares are not utilized when the effect is anti-dilutive. For the three months ended September 30, 2026 and 2025 basic and diluted income per share were the same, as all securities had an anti-dilutive effect.
| F-10 |
| Table of Contents |
The following table presents potentially dilutive securities that were not included in the computation of diluted net income per share as their inclusion would be anti-dilutive as of September 30:
|
| 2026 |
|
| 2025 |
| ||
|
|
|
|
|
|
| ||
Convertible preferred stock |
|
|
|
|
|
| ||
Fair Value of Financial Instruments
Assets and liabilities measured at fair value on a recurring basis
We recognize financial instruments under the following fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:
| Level 1: | quoted prices (unadjusted) in active markets for identical assets or liabilities; | |
|
|
| |
| Level 2: | observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and | |
|
|
| |
| Level 3: | assets and liabilities whose significant value drivers are unobservable. | |
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
The Company will update its assumptions each reporting period based on new developments and record such amounts at fair value based on the revised assumptions until the agreements expire or contingency is resolved, as applicable.
As of September 30, 2026 and June 30, 2026 the Company did not have any assets and liabilities measured at fair value on a recurring basis.
Assets and liabilities not measured at fair value on a recurring basis
In addition to assets and liabilities that are measured at fair value on a recurring basis, we also measure certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, property and equipment, intangible assets, and operating lease right-of-use assets are measured at fair value when there is an indication of impairment and the carrying amount exceeds the asset’s projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized.
As of September 30, 2026 and June 30, 2026, the fair values of cash, receivables, prepaid expenses and other current assets, accounts payable, and accrued expenses approximated their carrying values because of their short-term nature.
Recently Issued Accounting Pronouncements
There were no new accounting pronouncements issued or proposed by the FASB during the three months ended September 30, 2026 and through the date of filing this report which the Company believes will have a material impact on its financial statements.
| F-11 |
| Table of Contents |
3. GOING CONCERN
Historically, the Company has reported recurring net losses from operations and used net cash in operating activities. As of September 30, 2026, the Company’s current liabilities exceeded its current assets by $
The accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The ability of the Company to reach and maintain a successful level of operations is dependent on the execution of management’s plans, which include the raising of capital through the debt and/or equity markets, until such time that funds provided by operations are sufficient to fund working capital requirements. If the Company were not to continue as a going concern, it would likely not be able to realize its assets at values comparable to the carrying value or the fair value estimates reflected in the balances set out in the preparation of the financial statements.
There can be no assurances that the Company will be successful in attaining a profitable level of operations or in generating additional cash from the equity/debt markets or other sources fund its operations. The financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary. Should the Company not be successful in its business plan or in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all operational activities and/or contemplate the sale of its assets, if necessary.
4. OPERATING SEGMENTS
Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is the Chief Executive Officer. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s reportable operating segments. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.
Prior to June 11, 2025, the Company operated as a single operating segment, focusing on distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management.
Starting June 11, 2025, the Company has two reportable segments, focusing on distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management, and developing real estate opportunities, designed to attract healthcare providers and wellness clinic operators.
For the three months ended September 30, 2026 and 2025, there were no intersegment revenues or costs of revenues that needed to be eliminated in the Consolidated Statements of Operations.
The pharmaceutical products distribution company generates revenue through product sales and commissions. Real estate development company generates revenue through rental income. On June 1, 2026, the Company’s only rental customer informed the Company they would not be renewing their lease, thus there was no real estate segment operating activity in the three months ended September 30, 2026.
| F-12 |
| Table of Contents |
The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended September 30, 2026.
|
| Pharmaceutical Products Distribution |
|
| Real Estate Development |
|
| Total |
| |||
Revenue |
| $ |
|
| $ |
|
| $ |
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative[1] |
|
|
|
|
|
|
|
|
| |||
Depreciation and amortization |
|
|
|
|
|
|
|
|
| |||
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment net income (loss) from operations |
| $ | ( | ) |
| $ |
|
| $ | ( | ) | |
[1] | General and administrative costs consist mainly of professional fees, salaries and wages, executive compensation, information technology and software, and other payment processing fees. | ||||||||||||
The following table illustrates the reconciliation of segment operating income to net income before taxes for the three months ended September 30, 2026.
|
| September 30, 2026 |
| |
Segment loss from operations |
| $ | ( | ) |
|
|
|
|
|
Reconciling items |
|
|
|
|
Interest expense |
|
| ( | ) |
|
|
|
|
|
Net income (loss) from continued operations before income taxes |
| $ | ( | ) |
5. PROPERTY AND EQUIPMENT
Property and equipment consisted of the following as of:
|
| September 30, 2026 |
|
| June 30, 2026 |
| ||
|
|
|
|
|
|
| ||
Furniture and equipment |
| $ |
|
| $ |
| ||
Leasehold improvements |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Total |
|
|
|
|
|
| ||
Less accumulated depreciation and amortization |
|
| ( | ) |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
Net |
| $ |
|
| $ |
| ||
During the three months ended September 30, 2026 the Company disposed of its fully depreciated leasehold improvements for no gain or loss. Depreciation expense for the three months ended September 30, 2026 and 2025 was $
| F-13 |
| Table of Contents |
6. INTANGIBLE ASSETS
Intangible assets consisted of the following as of:
|
| Useful Lives |
| September 30, 2026 |
|
| June 30, 2026 |
| ||
|
|
|
|
|
|
|
|
| ||
Website |
|
| $ |
|
| $ |
| |||
Less accumulated amortization |
|
|
|
| ( | ) |
|
| ( | ) |
Net website |
|
|
| $ |
|
| $ |
| ||
Amortization expense for the three months ended September 30, 2026 and 2025 was $
7. RELATED PARTY TRANSACTIONS
We have one executive officer, Steve Rubakh, who is currently the sole member of our Board of Directors. The Board of Directors establishes Mr. Rubakh’s annual salary, cash bonuses, and the number of Series B preferred stock to issue Mr. Rubakh as additional compensation. Effective January 1, 2024, the Board of Directors approved Mr. Rubakh’s annual salary at $
During the three months ended September 30, 2026 and 2025,
Total compensation expense included in general and administrative expenses was $
8. NOTES PAYABLE
On June 15, 2022, the Company entered into a Loan Agreement and Promissory Note with BHP Capital NY, Inc. (“BHP”) in the amount of $
9. CONVERTIBLE NOTES PAYABLE
On July 21, 2026, the Company entered into a convertible note payable for $
| F-14 |
| Table of Contents |
10. SERIES C CONVERTIBLE PREFERRED STOCK
Effective August 1, 2025, the Company amended and restated the Certificate of Designation for its Series C Preferred Stock, effecting the consolidation of the Series C Preferred Stock and Series D Preferred Stock classes into a single series of convertible preferred stock. Per the share exchange agreement,
Dividends. Holders of Series C Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, dividends on shares of Series C Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the Company’s Common Stock (the “Common Stock”) when, as and if such dividends are paid on shares of the Common Stock.
Voting Rights. The Series C Convertible Preferred Stock will vote together with the Common Stock on an as-converted basis subject to certain beneficial ownership limitations. In addition, for as long as any shares of Series C Convertible Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series C Convertible Preferred Stock (a) amend or alter the rights, powers, or preferences of the Series C Convertible Preferred Stock; (b) authorize or issue any class of stock senior to, or otherwise pari passu with, the Series C Convertible Preferred Stock; (c) amend the Company’s charter documents in a way that adversely affects the Series C Convertible Preferred Stock; (d) increase the number of authorized shares of Series C Convertible Preferred Stock; or (e) enter into any agreement with respect to any of the foregoing.
Liquidation. Upon any Liquidation (as defined in the Certificate of Amendment), holders of Series C Convertible Preferred Stock shall be entitled to receive the Stated Value of their shares plus any accrued and unpaid dividends or other applicable fees, before any distribution is made to holders of junior securities. If the Company’s assets are insufficient to pay all such amounts in full, they will be distributed pro rata among holders of Series C Convertible Preferred Stock based on the amounts otherwise payable.
Conversion. Each share of Series C Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into the number of shares of Common Stock, subject to certain ownership limitations set forth in the Certificate of Amendment. The number of shares of Common Stock issuable upon conversion by dividing the Stated Value of the Series C Convertible Preferred Stock by the Conversion Price, which equals to the previous Trading Day’s closing price of the Common Stock. The Conversion Price is subject to adjustments and restrictions set forth in Section 7 of the Certificate of Amendment.
As of September 30, 2026 the Company has
11. STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred Stock
Series A Preferred Stock
In March 2015, the Company filed with the State of Nevada a Certificate of Designation establishing the designations, preferences, limitations and relative rights of
The Company has
| F-15 |
| Table of Contents |
Series B Preferred Stock
On December 21, 2015, the Company filed a Certificate of Designation for a new Series B convertible preferred stock with the State of Nevada following approval by the board of directors of the Company. The company authorized
The Company had
Common Stock
As of September 30, 2026, we were authorized to issue up to
The Company had
During the three months ended September 30, 2026, no common stock was issued by the company. During the three months ended September 30, 2026,
During the three months ended September 30, 2025, the Company issued
12. COMMITMENTS AND CONTINGENCIES
Legal Matters
From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of the date of filing of this report, there were no pending or threatened lawsuits.
Short-Term Lease
In January 2026, the Company entered a
13. DISCONTINUED OPERATIONS
Through June 6, 2024, we operated our digital asset mining operations in a hosted facility in Granbury, Texas. As of June 7, 2024, all miners were disconnected from their power source and many were sold during the year ended June 30, 2025. All remaining mining equipment was impaired and depreciated during the three months ended September 30, 2025. This marked a strategic shift in the Company’s operations.
| F-16 |
| Table of Contents |
The following is a reconciliation of major classes of revenue and expenses classified as discontinued operations on our consolidated income statements:
|
| During the Three Months Ended September 30, |
| |||||
|
| 2026 |
|
| 2025 |
| ||
Major classes of line items constituting net income (loss) from discontinued operations |
|
|
|
|
|
| ||
Depreciation and amortization |
| $ |
|
| $ | ( | ) | |
Impairment expense |
|
|
|
|
| ( | ) | |
Total major classes of line items constituting net income (loss) from discontinued operations |
| $ |
|
|
| ( | ) | |
Digital Asset Mining - Expenses
During the three months ended September 30, 2025, we impaired mining equipment and recognized impairment expense of $
14. SUBSEQUENT EVENTS
Management has evaluated subsequent events according to the requirements of ASC Topic 855, and has none to report.
| F-17 |
| Table of Contents |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS
We believe that it is important to communicate our future expectations to our security holders and to the public. This report, therefore, contains statements about future events and expectations which are “forward-looking statements” within the meaning of Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934, including the statements about our plans, objectives, expectations and prospects under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You can expect to identify these statements by forward-looking words such as “may,” “might,” “could,” “would,” “will,” “anticipate,” “believe,” “plan,” “estimate,” “project,” “expect,” “intend,” “seek” and other similar expressions. Any statement contained in this report that is not a statement of historical fact may be deemed to be a forward-looking statement. Although we believe that the plans, objectives, expectations and prospects reflected in or suggested by our forward-looking statements are reasonable, those statements involve risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements, and we can give no assurance that our plans, objectives, expectations and prospects will be achieved.
Important factors that might cause our actual results to differ materially from the results contemplated by the forward-looking statements are contained in the “Risk Factors” section of and elsewhere in our Annual Report on Form 10-K for the year ended June 30, 2026 filed on October 13, 2026 and in our subsequent filings with the Securities and Exchange Commission. The following discussion of our results of operations should be read together with our financial statements and related notes included elsewhere in this report.
GENERAL
We were incorporated in the State of Nevada on March 22, 2011 under the name Lightcollar, Inc. In March 2015, we changed our name to EMS Find, Inc. On May 30, 2017, Integrated Ventures, Inc. (“Integrated Ventures”), a Nevada corporation, was formed as a wholly owned subsidiary of the Company. Pursuant to an Agreement and Plan of Merger dated May 30, 2017, Integrated Ventures was merged into the Company, with the Company being the surviving corporation and changing its name to Integrated Ventures, Inc. In July 2024, the Company formed three wholly-owned subsidiaries, MedWell Direct, LLC (“MedWell Direct”), MedWell Facilities, LLC (“MedWell Facilities”), and MedWell USA, LLC (“MedWell USA), all of which were organized in the State of Nevada. In June 2025, we changed our name to MedWellAI, Inc.
On August 29, 2024, the Company, through MedWell Direct, consummated its acquisition of 51% of the membership interests of Healthy Lifestyle USA LLC, a Florida limited liability company (“Healthy Lifestyle”).
We are a publicly traded company (OTCQB: MWAI), based in Clearwater, Florida, that is focused on earning commissions through the use of a fully automated e-commerce platform that connects in-office buyers with multiple FDA-registered 503B pharmacies, offering GLP-1 weight management therapies, peptides and other compounds.
The Company also markets a turnkey, custom solution for qualified procurement agents and resellers to market in-office use products.
This e-commerce platform enables procurement agents and resellers to market products to licensed healthcare providers, wellness spas and telemedicine companies in a 100% automated, cost-effective, efficient, compliant and profitable manner without requiring any infrastructure investment.
Key features of the platform include access to multiple 503B outsourcing facilities, over 100 products, personalized pricing, direct payment deposits, custom domain options, and onboarding support.
| 3 |
| Table of Contents |
The platform allows for seamless ordering, fulfillment, and shipping managed directly by the 503B facilities.
Financial
Revenues from commissions were $76,390 and $94,887 for the three months ended September 30, 2026 and 2025, respectively.
Rental income was $0 and $22,500 for the three months ended September 30, 2026 and 2025, respectively. Cost of revenues for rental income was $0 and $7,550 for the three months ended September 30, 2026 and 2025, respectively.
Historically, we have funded our operations primarily from cash generated from our commissions revenue, convertible notes payable and preferred stock. During the three months ended September 30, 2026 and 2025, we generated negative cash flow from operations. During the three months ended September 30, 2026 we received proceeds of $195,000 from a convertible note.
Recent Material Developments
On July 21, 2026, the Company entered into a convertible note payable for $225,000. The note matures on July 21, 2027 and bears a flat interest charge of $27,000 that shall not be reduced or pro-rated in the event of prepayment. In addition, upon an event of default the interest rate will be equal to the lesser of 24% or the maximum rate of interest under the law. The convertible note requires a payment of $126,000 on December 29, 2026 with payments of $21,000 each month thereafter until the maturity of the note. At anytime after an event of default, the holder may convert the note into common shares at a rate per share equal to 80% of the lowest trading price in the 10 trading days prior to conversion. The Company received net proceeds of $195,000 after recording a $25,000 original issue discount and $5,000 in debt discount for legal fees. The total debt discount of $30,000 will be amortized over the life of the loan.
RESULTS OF OPERATIONS
THREE MONTHS ENDED SEPTEMBER 30, 2026 COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2025
Revenues
Our commission revenues decreased to $76,390 during the three months ended September 30, 2026 from $94,887 during the three months ended September 30, 2025.
Our rental revenues decreased to $0 during the three months ended September 30, 2026 from $22,500 during the three months ended September 30, 2025. On June 1, 2026, our only lease customer notified the Company the lease would not be renewed.
Expenses
General and administrative expenses decreased to $316,195 in the three months ended September 30, 2026 from $428,771 in three months ended September 30, 2025. The decrease resulted primarily from non-cash stock-based compensation expense of $49,250 that occurred in the prior year and not the current year, a decrease in marketing expense and a decrease in wages due to two less employees compared to the prior year period.
Depreciation and amortization decreased to $6,125 in the three months ended September 30, 2026 from $8,307 in the three months ended September 30, 2025. The decrease is due to leasehold assets no longer being depreciated as they were fully amortized and disposed after the three months ended September 30, 2025.
| 4 |
| Table of Contents |
Other Income (Expense)
Our other income (expense) was comprised of the following for the three months ended September 30:
|
| Three Months Ended September 30, |
| |||||
|
| 2026 |
|
| 2025 |
| ||
|
|
|
|
|
|
| ||
Other income |
|
| - |
|
|
| 1,207 |
|
Interest expense |
| $ | (45,939 | ) |
| $ | (12,936 | ) |
Loss on exchange of Series C & D preferred shares |
|
| - |
|
|
| (241,918 | ) |
|
| $ | (45,939 | ) |
| $ | (253,647 | ) |
Other income decreased to $0 in the three months ended September 30, 2026 from $1,207 during the three months ended September 30, 2025.
Interest expense increased to $45,939 in the three months ended September 30, 2026 from $12,936 during the three months ended September 30, 2025. The increase was due to a one-time, up front interest charge on a new $225,000 convertible note, amortization of the convertible note debt discount and interest on an outstanding note.
During the three months ended September 30, 2025 we exchanged 1,125 Series C and 3,000 Series D preferred shares for 6,500 Series C convertible preferred shares. As a result, during the three months ended September 30, 2025 we recognized a $241,918 loss on exchange of Series C and D preferred shares.
Discontinued Operations
During the three months ended September 30, 2025, we recognized net losses from discontinued operations of $72,719, as the Company strategically moved from the digital asset mining industry to health and wellness industry.
Net Loss Attributable to shareholders
During the three months ended September 30, 2026 and 2025, we reported a net loss attributable to shareholders of $287,173 and $651,878, respectively.
LIQUIDITY AND CAPITAL RESOURCES
Overview
As of September 30, 2026, we had total current assets of $198,069, including cash of $180,040 and total current liabilities of $8,331,076. We had total stockholders’ deficit attributable to shareholders of $8,266,584 as of September 30, 2026 compared to $7,979,411 as of June 30, 2026.
Sources and Uses of Cash
During the three months ended September 30, 2026, we used cash in operations of $101,182 as a result of our net loss from continuing operations of $291,869, other non-cash expenses of $11,961, decrease in receivables of $6,070, decrease in prepaids of $1,556, increase in accounts payable of $5,189, increase in accrued expenses of $34,985, and an increase of $130,926 to due to related party.
During the three months ended September 30, 2025, we used cash in operations of $170,781 as a result of our net loss from continuing operations of $580,888, loss on exchange of Series C & D preferred shares of $241,918, lease costs exceeding leases payments of $7,550, other non-cash expenses of $57,557, decrease in receivables of $287, and increases in accrued expenses of $13,309, and due to related party of $118,588 offset by increases in prepaid expenses of $1,244, accounts payable of $27,655, and deferred revenue of $203.
During the three months ended September 30, 2026, there were no cash flows from investing activities. During the three months ended September 30, 2025, we used net cash in investing activities – continuing operations of $7,308, comprised of cash used for leasehold improvements.
During the three months ended September 30, 2026 we had cash flows from financing activities of $195,000 from a convertible note payable. During the three months ended September 30, 2025, we had no cash flows from financing activities.
| 5 |
| Table of Contents |
Going Concern
Historically, the Company has reported recurring net losses from operations and used net cash in operating activities. As of September 30, 2026, the Company’s current liabilities exceeded its current assets by $8,133,007 and the Company had an accumulated deficit of $90,550,518. These conditions raise substantial doubt about the Company's ability to continue as a going concern.
The accompanying consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The ability of the Company to reach a successful level of operations is dependent on the execution of management’s plans, which include the raising of capital through the debt and/or equity markets, until such time that funds provided by operations are sufficient to fund working capital requirements. If the Company were not to continue as a going concern, it would likely not be able to realize its assets at values comparable to the carrying value or the fair value estimates reflected in the balances set out in the preparation of the consolidated financial statements.
There can be no assurances that the Company will be successful in attaining a profitable level of operations or in generating additional cash from the equity/debt markets or other sources to fund its operations. The consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary. Should the Company not be successful in its business plan or in obtaining the necessary financing to fund its operations, the Company would need to curtail certain or all operational activities and/or contemplate the sale of its assets, if necessary.
SIGNIFICANT ACCOUNTING POLICIES
Our significant accounting policies are disclosed in Note 2 to the accompanying financial statements. The following is a summary of those accounting policies that involve significant estimates and judgment of management.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.
Receivables
Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.
Property and Equipment
Property and equipment, consisting primarily of computer, other equipment, and leasehold improvements is stated at the lower of cost or estimated realizable value and is depreciated when placed into service using the straight-line method over estimated useful lives. Management has assessed the basis of depreciation of these assets and believes they should be depreciated over three – five years depending on the asset. Computers, due to their technological obsolescence reflecting rapid development of hardware that have faster processing capacity and other factors are depreciated over three years. Leasehold improvements are depreciated over five years representing the lease term. Maintenance and repairs are expensed as incurred and improvements are capitalized. Gains or losses on the disposition of property and equipment are recorded upon disposal.
Payments to equipment suppliers prior to shipment of the equipment are recorded as equipment deposits.
| 6 |
| Table of Contents |
Intangible Assets
The Company accounts for its intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill. ASC Subtopic 350-30, which requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC Subtopic 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs to renew or extend the term of intangible assets are recognized as an expense when incurred.
Impairment of Long-Lived Assets
All assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset may not be recoverable in accordance with ASC 350 and ASC 360. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value or net realizable value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.
Discontinued Operations
The Company follows the provisions of ASC 205-20, Presentation of Discontinued Operations, which requires separate reporting if a company sells part of its business. In order to recognize discontinued operation a major product line or division of an entity must be both a component and a strategic shift in operations.
Convertible Preferred Stock
The Company follows the provisions of ASC 480, Distinguishing Liabilities from Equity in determining if a financial instrument should be classified as a liability or equity on the balance sheet. This standard provides, among others, that the conversion of preferred stock into a variable number of equity shares and at inception, the monetary value is fixed, the instrument should be classified as a liability. As such upon the exchange of the Series C & D preferred shares on August 1, 2025 into convertible preferred stock, the Company determined the Series C convertible preferred stock met the requirements to be classified as a liability. Further, due to their convertible nature at any time at the option of the holder they are presented as current liability on the balance sheet.
Stock-Based Compensation
The Company accounts for all equity-based payments in accordance with ASC Topic 718, Compensation – Stock Compensation. ASC Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock awards, stock options, warrants and other equity-based compensation issued. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The fair value of a stock award is recorded at the fair market value of a share of the Company’s stock on the grant date. The Company estimates the fair value of stock options and warrants at the grant date by using an appropriate fair value model such as the Black-Scholes option pricing model or multinomial lattice models.
The Company accounts for non-employee share-based awards based upon ASC 505-50, Equity-Based Payments to Non-Employees. ASC 505-50 requires the costs of goods and services received in exchange for an award of equity instruments to be recognized using the fair value of the goods and services or the fair value of the equity award, whichever is more reliably measurable. The fair value of the equity award is determined on the measurement date, which is the earlier of the date that a performance commitment is reached or the date that performance is complete. Generally, our awards do not entail performance commitments. When an award vests over time such that performance occurs over multiple reporting periods, we estimate the fair value of the award as of the end of each reporting period and recognize an appropriate portion of the cost based on the fair value on that date. When the award vests, we adjust the cost previously recognized so that the cost ultimately recognized is equivalent to the fair value on the date the performance is complete.
| 7 |
| Table of Contents |
Revenue Recognition
We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. This standard provides a single comprehensive model to be used in the accounting for revenue arising from contracts with customers, including industry-specific guidance. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.
The following table presents the Company’s revenue by revenue source:
|
| Three Months Ended September 30, |
| |||||
|
| 2026 |
|
| 2025 |
| ||
|
|
|
|
|
|
| ||
Commissions |
| $ | 76,390 |
|
| $ | 94,887 |
|
Rental income |
|
| - |
|
|
| 22,500 |
|
|
| $ | 76,390 |
|
| $ | 111,877 |
|
Commissions
The Company earns commissions by informing, educating, and initiating sales of health and wellness products offered by a third party to customers. The commissions earned are based on the gross sales of products to customers less costs and fees. Periodically, the third party computes the commission payable since the previous Reconciliation Date. The third party then pays the Company the amount due. The transactions price is set as the commissions to be received based on the agreed terms. The commissions are earned at a point in time upon the successful sale of products to a customer.
The timing of commission revenue recognition may differ from the timing of payment by the Company’s customers. The Company records a receivable when revenue is recognized prior to payment and there is an unconditional right to payment. As of September 30, 2026, the Company had receivables from commissions of $3,029.
| 8 |
| Table of Contents |
Rental Income
The Company recognizes rent revenue from the lease of its sub-leased properties in accordance with ASC 842, Leases. The sub-lease is categorized as an operating lease according to ASC criteria for the lease definitions. Rent revenue is recognized on a straight-line basis over the lease term, reflecting the pattern of the economic benefits derived from the lease.
The Company’s leases generally have fixed rental payments over the lease term, with occasional escalations based on predetermined factors. Rent revenue is recognized monthly as the lessor fulfills its obligations under the lease agreement.
Any lease incentives or concessions provided to lessees, such as rent-free periods or tenant improvement allowances, are recognized as a reduction of rent revenue over the lease term.
During the year ended June 30, 2026, the Company had only one lease arrangement with a single customer. On June 1, 2026 the customer notified the Company the lease would not be renewed.
Fair Value of Financial Instruments
Assets and liabilities measured at fair value on a recurring basis
We recognize financial instruments under the following fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:
| Level 1: | quoted prices (unadjusted) in active markets for identical assets or liabilities; | |
|
|
| |
| Level 2: | observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and | |
|
|
| |
| Level 3: | assets and liabilities whose significant value drivers are unobservable. | |
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
| 9 |
| Table of Contents |
The Company will update its assumptions each reporting period based on new developments and record such amounts at fair value based on the revised assumptions until the agreements expire or contingency is resolved, as applicable.
As of September 30, 2026 and June 30, 2026 the Company did not have any assets and liabilities measured at fair value on a recurring basis.
OFF BALANCE SHEET ARRANGEMENTS
As of September 30, 2026, we have no off-balance sheet arrangements.
RECENTLY ISSUED ACCOUNTING POLICIES
There were no new accounting pronouncements issued or proposed by the FASB during the three months ended September 30, 2026 and through the date of filing this report which the Company believes will have a material impact on its financial statements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a smaller reporting company, as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this item.
ITEM 4. CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered in this report, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. To address the material weaknesses, we performed additional analysis and other post-closing procedures in an effort to ensure our financial statements included in this quarterly report have been prepared in accordance with generally accepted accounting principles. Accordingly, management believes that the financial statements included in this report fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Securities Exchange Act, as amended. Our management assessed the effectiveness of our internal control over financial reporting as of September 30, 2026. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. We have identified the following material weaknesses:
| 10 |
| Table of Contents |
1. | As of September 30, 2026, we did not maintain effective controls over the control environment. Specifically, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness. | |
2. | As of September 30, 2026, due to the inherent issue of segregation of duties in a small company, we have relied heavily on entity or management review controls and engaged an outside financial consultant to lessen the issue of segregation of duties over accounting, financial close procedures and controls over financial statement disclosure. Accordingly, management has determined that this control deficiency constitutes a material weakness. | |
|
|
|
| 3. | As of September 30, 2026, we did not establish a written policy for the approval, identification and authorization of related party transactions. Accordingly, management has determined that this control deficiency constitutes a material weakness. |
Because of these material weaknesses, management has concluded that the Company did not maintain effective internal control over financial reporting as of September 30, 2026, based on the criteria established in “Internal Control-Integrated Framework” issued by the COSO.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting through the date of this report or during the quarter ended September 30, 2026, that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
| 11 |
| Table of Contents |
PART II
ITEM 1. LEGAL PROCEEDINGS
We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company, threatened against or affecting our company, our common stock, or our company’s directors, officers or affiliates, or in which any owner of record or beneficial owner of more than 5% of any class of our voting securities is a party adverse to us or has a material interest adverse to us.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended June 30, 2026.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES
During the three months ended September 30, 2026, no shares of common stock were issued.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
As of September 30, 2026, the Company was in default on a $500,000 promissory note that matured on January 15, 2023. As of the date of this report, the total arrearage was $611,799, consisting of $500,000 in principal and $111,799 in interest.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
During the three months ended September 30, 2026, no director or officer of the Company
There is no other information required to be disclosed under this item which was not previously disclosed.
| 12 |
| Table of Contents |
ITEM 6. EXHIBITS
EXHIBIT INDEX
Exhibit Number |
| Exhibit Description |
31.1* |
| Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer and Principal Financial Officer |
|
|
|
32.1** |
| Section 1350 Certification of Principal Executive Officer and Principal Financial Officer |
|
|
|
101.INS* |
| Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
|
|
|
101.SCH* |
| Inline XBRL Taxonomy Extension Schema |
|
|
|
101.CAL* |
| Inline XBRL Taxonomy Extension Calculation Linkbase |
|
|
|
101.DEF* |
| Inline XBRL Taxonomy Extension Definition Linkbase |
|
|
|
101.LAB* |
| Inline XBRL Taxonomy Extension Label Linkbase |
|
|
|
101.PRE* |
| Inline XBRL Taxonomy Extension Presentation Linkbase |
|
|
|
104* |
| Cover Page Interactive Data File (formatted inline XBRL and contained in Exhibit 101) |
_________
* Filed herewith.
** Furnished herewith. This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Company specifically incorporates it by reference, in accordance with Item 601(b)(32)(ii) of Regulation S-K.
| 13 |
| Table of Contents |
SIGNATURES
In accordance with the requirements of the Exchange Act, the Company has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MEDWELLAI, INC. | |||
Dated: November 16, 2026 | By: | /s/ Steve Rubakh | |
Chief Executive Officer, Chief Financial Officer, and Director (Principal Executive Officer and Principal Financial and Accounting Officer) | |||
| 14 |